Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy.
We present a 16-year old girl with Prader-Willi syndrome who developed cardiac tamponade as an initial finding of systemic lupus erythematosus. Until one year prior to this episode, she had received growth hormone treatment for nine years. The association among Prader-Willi syndrome, growth hormone treatment and systemic lupus erythematosus is discussed.
Kuramochi
Y
Y
Department of Pediatrics, Shizuoka Medical Center, Shizuoka, Japan. kuramochi2005@yahoo.co.jp
Kato
T
T
Sudou
M
M
Sugano
H
H
Takagi
H
H
Morita
T
T
D000293:Adolescent; D002305:Cardiac Tamponade / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D004322:Drainage; D004334:Drug Administration Schedule; D004452:Echocardiography; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D013006:Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D011218:Prader-Willi Syndrome / Q000150:complications* / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D013902:Radiography, Thoracic; D014057:Tomography, X-Ray Computed
D005938:Glucocorticoids; D013006:Growth Hormone; D011239:Prednisolone